Syneos Health to Present at the UBS Virtual Global Healthcare Conference
14 May 2020 - 2:15AM
Syneos Health® (Nasdaq:SYNH), the only fully integrated
biopharmaceutical solutions organization combining a CRO (Contract
Research Organization) and a CCO (Contract Commercial
Organization), today announced that Chief Executive Officer
Alistair Macdonald and Chief Financial Officer Jason Meggs are
scheduled to present at the UBS Virtual Global Healthcare
Conference on Tuesday, May 19, 2020, at 9:10 a.m. ET.
A live webcast of the event, along with a link
to the presentation materials and archived audio replay of the
presentation, will be available on the Company’s Investor Relations
website at investor.syneoshealth.com.
About Syneos HealthSyneos
Health® (Nasdaq:SYNH) is the only fully integrated
biopharmaceutical solutions organization. The Company, including a
Contract Research Organization (CRO) and Contract Commercial
Organization (CCO), is purpose-built to accelerate customer
performance to address modern market realities. We bring together
approximately 24,000 clinical and commercial minds with the ability
to support customers in more than 110 countries. Together we share
insights, use the latest technologies and apply advanced business
practices to speed our customers’ delivery of important therapies
to patients. To learn more about how we are shortening the
distance from lab to life®, visit syneoshealth.com or
subscribe to our podcast. Contacts
Investor Relations: Ronnie Speight Senior Vice
President, Investor Relations +1 919 745 2745
Investor.Relations@syneoshealth.com
Press/Media: Danielle DeForge Executive
Director, External Communications +1 202 210 5992
danielle.deforge@syneoshealth.com
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024